Inpharmatica
Latest round
- Series C
Last raised
- Nov 2004
Total raised
- $69M
Investors
- 8
About Inpharmatica
Inpharmatica, founded in 1998 and headquartered in London, UK, focuses on enhancing drug discovery through innovative informatics solutions. The company has undergone no significant pivots and does not have known subsidiaries. The founder's history is not detailed.Inpharmatica offers a suite of advanced services that enhance drug discovery through predictive informatics in medicinal chemistry and ADME (Absorption, Distribution, Metabolism, and Excretion). Central to their offerings are proprietary technologies such as Chemogenomics, which leverages extensive drug discovery databases to streamline the identification of viable drug candidates. Additionally, their Silico services combine optimization techniques with in silico tools, providing clients with expert assessments that aid in the early selection of compounds with desirable properties. These services are tailored for collaborations, project-based engagements, or licensing opportunities, catering primarily to global pharmaceutical and biotechnology companies, including industry leaders like Pfizer, GSK, and Sanofi-Aventis.Inpharmatica generated revenue of GBP 25,463,244 in 2023, with an EBITDA of GBP 682,677. The company generates revenue through a combination of service contracts, research collaborations, and licensing agreements for its proprietary technologies. Transactions primarily occur on a B2B basis with pharmaceutical and biotechnology companies, where clients engage in tailored research projects or subscribe to specific services, including access to Inpharmatica’s unique databases like StARLITe™, DrugStore™, and GPCR SARfari™.Inpharmatica plans to expand its product offerings by launching new services designed to meet the evolving needs of the pharmaceutical industry.
Who invested in Inpharmatica
8 investors across 2 rounds
See all investors in Inpharmatica
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Inpharmatica
Who invested in Inpharmatica?
Inpharmatica has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Inpharmatica raised?
Inpharmatica has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Inpharmatica last raise money?
Inpharmatica's most recent round on record is a Series C, in Nov 2004.
What does Inpharmatica do?
Inpharmatica, founded in 1998 and headquartered in London, UK, focuses on enhancing drug discovery through innovative informatics solutions.
Where is Inpharmatica headquartered?
Inpharmatica is headquartered in London, UK.
Which VCs invest in companies like Inpharmatica?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back healthcare it companies at Inpharmatica's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series C
Raising like Inpharmatica? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.